{"DataElement":{"publicId":"7542503","version":"1","preferredName":"Tumor Identifier Domain Malignant Neoplasm Diagnosis Information Type","preferredDefinition":"A description of the type of malignancy based on its inherent properties/characteristics.","longName":"TU_SUPPTU_QVAL_SMNTYP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7381139","version":"1","preferredName":"Tumor Identifier Domain Malignant Neoplasm Diagnosis Information","preferredDefinition":"A domain that represents the data that uniquely identifies tumors._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Knowledge derived from study, experience, or instruction that has been gathered or received by communication.","longName":"6607938v1.0:7429665v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6607938","version":"1","preferredName":"Tumor Identifier Domain","preferredDefinition":"A domain that represents the data that uniquely identifies tumors.","longName":"C106577","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Identifier Domain","conceptCode":"C106577","definition":"A domain that represents the data that uniquely identifies tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1D6F05-C099-2E3D-E053-F662850A5D84","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7429665","version":"1","preferredName":"Malignant Neoplasm Diagnosis Information","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication.","longName":"C9305:C15220:C48191","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Information","conceptCode":"C48191","definition":"Knowledge derived from study, experience, or instruction that has been gathered or received by communication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFEE232B-9E4F-628A-E053-4EBD850AB423","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC38F086-AFBA-12E8-E053-4EBD850AD022","latestVersionIndicator":"Yes","beginDate":"2020-08-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-08-06","modifiedBy":"GALITG","dateModified":"2021-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7542500","version":"1","preferredName":"Malignant Neoplasm Type","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Something distinguishable as an identifiable class based on common qualities.","longName":"7542500v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Second malignancy","valueDescription":"Malignant Neoplasm Second","ValueMeaning":{"publicId":"7542501","version":"1","preferredName":"Second Malignant Neoplasm","longName":"7542501v1.00","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7B33E23-9DC2-6E90-E053-4EBD850A715C","latestVersionIndicator":"Yes","beginDate":"2020-12-30","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-30","modifiedBy":"KUMMEROA","dateModified":"2023-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B7B33E23-9DDD-6E90-E053-4EBD850A715C","beginDate":"2020-12-30","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-30","modifiedBy":"ONEDATA","dateModified":"2020-12-30","deletedIndicator":"No"},{"value":"Secondary malignancy","valueDescription":"Secondary Carcinoma","ValueMeaning":{"publicId":"6832484","version":"1","preferredName":"Secondary Carcinoma","longName":"6832484","preferredDefinition":"A carcinoma that arises from a pre-existing lower grade epithelial lesion, or as a result of a primary carcinoma that has spread to secondary sites, or due to a complication of a cancer treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary Carcinoma","conceptCode":"C36310","definition":"A carcinoma that arises from a pre-existing lower grade epithelial lesion, or as a result of a primary carcinoma that has spread to secondary sites, or due to a complication of a cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9A76BA-998A-69B5-E053-F662850AA843","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B7B33E23-9DB5-6E90-E053-4EBD850A715C","beginDate":"2020-12-30","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-30","modifiedBy":"ONEDATA","dateModified":"2020-12-30","deletedIndicator":"No"},{"value":"Non-Measurable","valueDescription":"Non-Measurable Tumor Identification","ValueMeaning":{"publicId":"6626831","version":"1","preferredName":"Non-Measurable Tumor Identification","longName":"6626831","preferredDefinition":"The identification of a tumor that is incapable of being measured at baseline.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Measurable Tumor Identification","conceptCode":"C103423","definition":"The identification of a tumor that is incapable of being measured at baseline.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80D76D8F-CFBA-30FC-E053-F662850A8808","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-01","modifiedBy":"ONEDATA","dateModified":"2019-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B841997D-0676-37F3-E053-4EBD850AFF01","beginDate":"2021-01-06","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-06","modifiedBy":"ONEDATA","dateModified":"2021-01-06","deletedIndicator":"No"},{"value":"Measurable","valueDescription":"Measurable","ValueMeaning":{"publicId":"2574012","version":"1","preferredName":"Measurable","longName":"2574012","preferredDefinition":"Capable of being measured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable","conceptCode":"C37894","definition":"Capable of being measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE29-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-12","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-12","modifiedBy":"REEVESD","dateModified":"2012-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B841997D-0680-37F3-E053-4EBD850AFF01","beginDate":"2021-01-06","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-06","modifiedBy":"ONEDATA","dateModified":"2021-01-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2684692","version":"1","preferredName":"Malignant Neoplasm Type","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Type; a subdivision of a particular kind of thing.","longName":"C9305:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AFC11F7-407B-1DA1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-25","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-25","modifiedBy":"ONEDATA","dateModified":"2007-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7B33E23-9D93-6E90-E053-4EBD850A715C","latestVersionIndicator":"Yes","beginDate":"2020-12-30","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-30","modifiedBy":"KUMMEROA","dateModified":"2023-02-20","changeDescription":null,"administrativeNotes":"2023.2.20 Updated order of PV concepts. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"},{"publicId":"6540049","version":"1","longName":"SSPedi (Symptom Screening in Pediatrics)","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"SUPPTU_QVAL_TUDZTYP","type":"COG Form Element","context":"COG"},{"name":"SUPPTU_QVAL_SMN","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Type of disease assessed:","url":null,"context":"COG"},{"name":"Type of malignancy:","type":"Preferred Question Text","description":"Type of malignancy:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Type of neoplasm:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7B3DFCC-D665-69E0-E053-4EBD850AA6BD","latestVersionIndicator":"Yes","beginDate":"2020-12-30","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-30","modifiedBy":"MMADDINENI","dateModified":"2024-01-25","changeDescription":"1/29/21GG Retired/inadvertent duplicate of 6941899 which is NCI Standard.","administrativeNotes":"2023.5.31 Reviewed and released per quarterly report. ak 2023.2.20 Took out of retirement. Needed on 3 forms with PVs in VD 7542500. ak","unresolvedIssues":null,"deletedIndicator":"No"}}